HR-LCMS analysis of phytochemicals from Bignonia magnifica and evaluation of antioxidant activity using the FRAP method
The Journal of Phytopharmacology · 17.04.2026 · 15 (2) · 135-143
DOI: 10.31254/phyto.2026.15203 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Phytopharmacology, online erschienen am 17.04.2026. Verfasst von Kyadagi Ravikumara und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Bignonia magnifica, known as glow vine or purple funnel vine, is a stunning evergreen climber from the Bignoniaceae family, native to humid forests in Colombia, Ecuador, Panama, and Venezuela. It has an aesthetic value and potential medicinal properties.
Objectives
The present study was carried out to evaluate phytochemical compositions and antioxidant activity of B. magnifica leaf extracts. Materials and Methods: Sequential leaf extraction was performed by Soxhlet apparatus using Chloroform, Ethyl acetate, Ethanol and Methanol solvents. The qualitative and quantitatively estimation of phytochemical constituents by using standard procedure. High Resolution- Liquid Chromatography Mass Spectroscopy analysis to identify bioactive compounds. The antioxidant activity was evaluated by ferric reducing antioxidant power assay.
Results
Preliminary phytochemical screening of leaf extracts revealed the presence of carbohydrates, tannins, phenols, flavonoids, terpenoids, proteins, alkaloids, saponins, glycosides, and cardiac glycosides. The Quantitative analysis indicates that the ethyl acetate solution has a high phenolic content (49.50±0.07 mg/g) and tannin (506.00±0.041TAE) content. In contrast, the chloroform infusion shows increased flavonoid levels (4.00±0.001mg/gQE), terpenoids (1.42±0.002mg-TPE/g) and alkaloids (16.50±0.58%). The FRAP assay measures the antioxidant task and demonstrates that ethyl acetate (2241.07±0.01mg/gAAE) infusion has a greater diminishing effect than chloroform (1062.50±0.01 mg/gAAE) infusion. The HR-LCMS analysis identified bioactive compounds such as Genistein, Hydroquinidine, 7',8'-Dihydro-8' hydroxycitraniaxanthin, 14,19- Dihydroaspidospermatine, Pyrrhoxanthinol, Notoginsenoside R10.
Conclusion
These findings indicate that the B. magnifica leaf contain a significant amount of bioactive substances and natural antioxidants, which supports the idea that the leaf could be used as a curative agent in the treatment of oxidative stress disorders and medicinal properties.
Zitieren
APA
Ravikumara, K., Kaveri, T. M., & Umesha, S. (2026). HR-LCMS analysis of phytochemicals from Bignonia magnifica and evaluation of antioxidant activity using the FRAP method. The Journal of Phytopharmacology, 15(2), 135-143. https://doi.org/10.31254/phyto.2026.15203
Vancouver
Ravikumara K, Kaveri TM, Umesha S. HR-LCMS analysis of phytochemicals from Bignonia magnifica and evaluation of antioxidant activity using the FRAP method. The Journal of Phytopharmacology. 2026;15(2):135-143. doi:10.31254/phyto.2026.15203
BibTeX
@article{Ravikumara2026,
author = {Ravikumara, Kyadagi and Kaveri, Taralabalu Matt and Umesha, S.},
title = {HR-LCMS analysis of phytochemicals from Bignonia magnifica and evaluation of antioxidant activity using the FRAP method},
journal = {The Journal of Phytopharmacology},
year = {2026},
volume = {15},
number = {2},
pages = {135--143},
doi = {10.31254/phyto.2026.15203}
}
EUVIMED